Intrepid TMVR Device

CLINICAL TRIAL Apollo Transcatheter Mitral Valve Replacement (TMVR)


FOR PATIENTS WITH
SEVERE SYMPTOMATIC
MITRAL REGURGITATION

CAUTION: Investigational device. Limited by United States law to investigational use. Exclusively for Clinical Investigations.

Apollo Trial

As part of our commitment to developing solutions for the treatment of valve disease, Medtronic is sponsoring the landmark APOLLO Trial. APOLLO will evaluate transcatheter mitral valve replacement (TMVR) — a therapy designed to correct mitral regurgitation.

LEARN ABOUT THE TRIAL
See Which PATIENTS ARE ELIGIBLE
SEE PHYSICIANS & LOCATIONS